Cancer metastasis: Advances in the detection and characterization of disseminated tumour cells facilitate clinical translation

National Medical Journal of India

Volumn 18, Issue 5, 2005, Pages 250-255

  Balic, Marija ^a,c   Dandachi, Nadia ^b   Lin, Henry ^a   Datar, Ram H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

CANCER CELL CULTURE; CANCER RESEARCH; CANCER SURVIVAL; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL TYPE; DISSEMINATED CANCER; FLOW CYTOMETRY; HELA CELL; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; METASTASIS; MONONUCLEAR CELL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ISOLATION; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE;

HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASMS; RNA;

EID: 30844447915     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Lugo TG, Braun S, Cote RJ, Pantel K, Rusch V. Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 2003;21:2609-15.
2. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896-900.
3. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
4. Sienel W, Seen-Hibler R, Mutschler W, Pantel K, Passlick B. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: Detection rate and clinical significance. Eur J Cardiothorac Surg 2003;23:451-6.
5. Lukyanchuk VV, Friess H, Kleeff J, Osinsky SP, Ayuni E, Candinas D, et al. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients, with gastrointestinal cancers. Anticancer Res 2003;23:2711-16.
6. Heiss MM, Simon EH, Beyer BC, Gruetzner KU, Tarabichi A, Babic R, et al. Minimal residual disease in gastric cancer: Evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J Clin Oncol 2002;20:2005-16.
7. Vogel I, Kalthoff H. Disseminated tumour cells: Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001;439: 109-17.
8. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort study. Ann Surg 2004;239:828-37; discussion 837-40.
9. Pierga JY, Bonneton C, Vincent-Salomon A, de Cremoux P, Nos C, Blin N, et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004;10:1392-400.
10. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3:165-73.
11. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002;49:150-8.
12. Naume B, Borgen E, Beiske K, Herstad TK, Ravnas G, Renolen A, et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997;6:103-14.
13. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002;8: 1085-91.
14. Woelfle U, Breit E, Zafrakas K, Otte M, Schubert F, Muller V, et al. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. J Immunol Methods 2005;300:136-45.
15. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-8.
16. Gottschalk J, Jautzke G, Zimmer C, Cervos-Navarro J. HEA 125 and Ber EP4: Two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors. Clin Neuropathol 1993;12:68-72.
17. Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, et al. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 1998;78:556-60.
18. de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, et al. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res 2000;6: 3117-22.
19. Raynor M, Stephenson SA, Walsh DC, Pittman KB, Dobrovic A. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC Cancer 2002;2:14.
20. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
21. Balic M, Dandachi N, Hofmann G, Samonigg H, Loibner H, Obwaller A, et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 2005;68:25-30.
22. Huang Y, Yang J, Wang XB, Becker FF, Gascoyne PR. The removal of human breast cancer cells from hematopoietic CD34+ stem cells by dielectrophoretic field-flow-fractionation. J Hematother Stem Cell Res 1999;8:481-90.
23. Cheng J, Sheldon EL, Wu L, Heller MJ, O'Connell JP. Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip. Anal Chem 1998;70:2321-6.
24. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000;156:57-63.
25. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, et al. Enumeration of circulating tumor cells in the blood of breast cancer patients; after filtration enrichment: Correlation with disease stage. Breast Cancer Res Treat 2004;86:237-47.
26. Mohamed H, McCurdy LD, Szarowski DH, Duva S, Turner JN, Caggana M. Development of a rare cell fractionation device: Application for cancer detection. IEEE Trans Nanobioscience 2004;3:251-6.
27. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-94.
28. Gao X, Nie S. Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol 2003;21:371-3.
29. Arya H, Kaul Z, Wadhwa R, Taira K, Hirano T, Kaul SC. Quantum dots in bio-imaging: Revolution by the small. Biochem Biophys Res Commun 2005;329:1173-7.
30. George B, Cote RJ, Datar RH. Nucleic acids in disease prognosis. Natl Med J India 2001;14:163-7.
31. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
32. Sakaguchi M, Virmani A, Dudak MW, Peters GN, Leitch AM, Saboorian H, et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol 2003;10:117-25.
33. Wallace MB, Block M, Hoffman BJ, Hawes RH, Silvestri G, Reed CE, et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med 2003;167:1670-5.
34. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637-42.
35. Slade MJ, Singh A, Smith BM, Tripuraneni G, Hall E, Peckitt C, et al, Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years. Int J Cancer 2005;114:94-100.
36. Wharton RQ, Jonas SK, Glover C, Khan ZA, Klokouzas A, Quinn H, et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 1999;5:4158-63.
37. Pelkey TJ, Frierson HF Jr, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996;42:1369-81.
38. Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clin Chem 2002;48:1178-85.
39. Bustin SA, Benes V, Nolan T, Pfaffl MW. Quantitative real-time RT-PCR - a perspective. J Mol Endocrinol 2005;34:597-601.
40. Koyanagi K, Kuo C, Nakagawa T, Mori T, Ueno H, Lorico AR Jr, et al. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: Relation to disease stage in melanoma patients. Clin Chem 2005;51:981-8.
41. Schuster R, Max N, Mann B, Heufelder K, Thilo F, Grone J, et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 2004;108:219-27.
42. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques. Br J Cancer 2005;92:906-12.
43. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: Correlation with clinical stage of disease. Cancer Res 2001;61:8845-50.
44. Houghton RL, Dillon DC, Molesh DA, Zehentner BK, Xu J, Jiang J, et al. Transcriptional complementarity in breast cancer: Application to detection of circulating tumor cells. Mol Diagn 2001;6:79-91.
45. Hardingham JE, Hewett PJ, Sage RE, Finch JL, Nuttall JD, Kotasek D, et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 2000;89:8-13.
46. Vlems FA, Diepstra JH, Cornelissen IM, Ruers TJ, Ligtenberg MJ, Punt CJ, et al. Limitations of cytokeratin 20 RT-PCR to detect dissemmated tumour cells in blood and bone marrow of patients with colorectal cancer: Expression in controls and downregulation in tumour tissue. Mol Pathol 2002;55:156-63.
47. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
48. Choesmel V, Pierga JY, Nos C, Vincent-Salomon A, Sigal-Zafrani B, Thiery JP, et al. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: Clinical relevance. Breast Cancer Res 2004;6:R556-70.
49. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J Mol Endocrinol 2002;29:23-39.
50. Vlems FA, Ladanyi A, Gertler R, Rosenberg R, Diepstra JH, Roder C, et al. Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol. Eur J Cancer 2003;39: 388-96.
51. Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 2004;15:155-66.
52. Dandachi N, Balic M, Stanzer S, Haim M, Resel M, Hinterleitner AT, et al. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients. J Mol Diagn 2005;7:631-7.
53. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002;360:683-9.
54. Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O, et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol 2002;20:387-92.
55. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005;65:4993-7.
56. Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW, et al. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1995;1: 1035-9.
57. Braun S, Schlimok G, Heumos I, Schaller G, Riethdorf L, Riethmuller G, et al. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res 2001;61:1890-5.
58. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, et al. Circulating tumor cells in breast cancer: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005;11:3678-85.
59. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8.